Crestwood Advisors Group’s Editas Medicine EDIT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-12,960	Closed	-$107K	–	368
2023 Q2	$107K	Hold	12,960	–	–	﹤0.01%	248
2023 Q1	$94K	Sell	12,960 -2,750	-18%	-$19.9K	﹤0.01%	252
2022 Q4	$139K	Hold	15,710	–	–	﹤0.01%	254
2022 Q3	$192K	Sell	15,710 -2,000	-11%	-$24.4K	0.01%	249
2022 Q2	$210K	Sell	17,710 -450	-2%	-$5.34K	0.01%	243
2022 Q1	$345K	Sell	18,160 -1,150	-6%	-$21.8K	0.01%	230
2021 Q4	$513K	Sell	19,310 -1,170	-6%	-$31.1K	0.01%	202
2021 Q3	$841K	Sell	20,480 -5,180	-20%	-$213K	0.02%	161
2021 Q2	$1.45M	Sell	25,660 -2,500	-9%	-$142K	0.04%	135
2021 Q1	$1.18M	Sell	28,160 -300	-1%	-$12.6K	0.04%	141
2020 Q4	$2M	Sell	28,460 -1,790	-6%	-$125K	0.07%	117
2020 Q3	$849K	Sell	30,250 -2,000	-6%	-$56.1K	0.03%	135
2020 Q2	$954K	Hold	32,250	–	–	0.04%	123
2020 Q1	$640K	Sell	32,250 -525	-2%	-$10.4K	0.03%	139
2019 Q4	$970K	Sell	32,775 -19,425	-37%	-$575K	0.04%	138
2019 Q3	$1.19M	Sell	52,200 -5,800	-10%	-$132K	0.05%	121
2019 Q2	$1.44M	Hold	58,000	–	–	0.07%	118
2019 Q1	$1.42M	Sell	58,000 -27,281	-32%	-$667K	0.1%	69
2018 Q4	$1.94M	Hold	85,281	–	–	0.15%	63
2018 Q3	$2.71M	Hold	85,281	–	–	0.19%	62
2018 Q2	$2.5M	Sell	85,281 -200	-0.2%	-$5.87K	0.18%	63
2018 Q1	$2.83M	Hold	85,481	–	–	0.22%	61
2017 Q4	$2.63M	Sell	85,481 -4,656	-5%	-$143K	0.21%	62
2017 Q3	$2.16M	Sell	90,137 -49,211	-35%	-$1.18M	0.19%	61
2017 Q2	$2.39M	Buy	139,348 +23,411	+20%	+$401K	0.2%	62
2017 Q1	$2.37M	Buy	+115,937	New	+$2.37M	0.21%	61